EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cognitive Outcomes After Transcranial Magnetic Stimulation for the Treatment of Late-Life Depression: Résultats cognitifs après la stimulation magnétique transcrânienne pour le traitement de la dépression chez les personnes âgées

Katharina Göke, Shawn M McClintock, Linda Mah, Tarek K Rajji, Hyewon H Lee, Sean M Nestor, Jonathan Downar, Yoshihiro Noda iD, Zafiris J Daskalakis, Benoit H Mulsant iD, Daniel M Blumberger iD

The Canadian Journal of Psychiatry · 2025

DOI: 10.1177/07067437251315515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Canadian Journal of Psychiatry, 2025. Verfasst von Katharina Göke und 10 weiteren Autor:innen. Beteiligte Einrichtung: Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Depressive Disorder, Dorsolateral Prefrontal Cortex, Executive Function. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Late-life depression (LLD) is often accompanied by cognitive impairment, which may persist despite antidepressant treatment. Repetitive transcranial magnetic stimulation (rTMS) is an efficacious treatment for depression, with potential benefits on cognitive functioning. However, research on cognitive effects is inconclusive, relatively sparse in LLD, and predominantly focused on group-level cognitive changes. This study aimed to explore individual-level cognitive changes following rTMS treatment in patients with LLD.

Method

Data were analyzed from 153 patients with LLD from the FOUR-D study (ClinicalTrials.gov identifier: NCT02998580) who received bilateral standard rTMS or theta burst stimulation (TBS) targeting the dorsolateral prefrontal cortex (DLPFC). Cognitive function was assessed pre- and post-treatment using measures of executive function, information processing speed, and learning and memory. Reliable change indices, adjusted for practice effects and test-retest reliability, were employed to evaluate individual-level cognitive changes. Chi-square tests examined if proportions of cognitive improvers differed from expected proportions.

Results

Cognitive performance from baseline to end of treatment remained stable for most patients. Reliably improved performance was observed in 0.0% to 20.0% of participants across cognitive measures, while worsened performance was observed in 0.0% to 2.7%. A small but significant proportion (20.0%) of participants showed improvement in verbal learning.

Conclusions

Bilateral standard rTMS or TBS of the DLPFC in LLD yielded no substantial cognitive enhancing effects, although a small proportion showed improved verbal learning after treatment. Importantly, both interventions were cognitively safe with relatively stable performance across time. Future research is needed to explore approaches to enhance the cognitive benefits of standard rTMS and TBS in patients with LLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionDepressive DisorderDorsolateral Prefrontal CortexExecutive FunctionOutcome Assessment, Health CareTranscranial Magnetic StimulationAgedAged, 80 and overFemaleHumansMaleMiddle AgedCognitive EnhancementRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

cognitionexecutive functionlate-life depressionreliable change indexrepetitive transcranial magnetic stimulation

Autor:innen und Institutionen

  • Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Division of Psychology, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Rotman Research Institute, Baycrest Health Sciences, Toronto, ON, Canada.
  • Toronto Dementia Research Alliance, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Yoshihiro Noda, Benoit H Mulsant, Daniel M Blumberger

Förderung

  • Wellcome Trust
  • Canadian Institutes of Health Research

Zitieren

APA

Göke, K., McClintock, S. M., Mah, L., Rajji, T. K., Lee, H. H., Nestor, S. M., Downar, J., Noda, Y., Daskalakis, Z. J., Mulsant, B. H., & Blumberger, D. M. (2025). Cognitive Outcomes After Transcranial Magnetic Stimulation for the Treatment of Late-Life Depression: Résultats cognitifs après la stimulation magnétique transcrânienne pour le traitement de la dépression chez les personnes âgées. The Canadian Journal of Psychiatry. https://doi.org/10.1177/07067437251315515

Vancouver

Göke K, McClintock SM, Mah L, Rajji TK, Lee HH, Nestor SM, et al. Cognitive Outcomes After Transcranial Magnetic Stimulation for the Treatment of Late-Life Depression: Résultats cognitifs après la stimulation magnétique transcrânienne pour le traitement de la dépression chez les personnes âgées. The Canadian Journal of Psychiatry. 2025. doi:10.1177/07067437251315515

BibTeX
@article{Gke2025,
  author = {Göke, Katharina and McClintock, Shawn M and Mah, Linda and Rajji, Tarek K and Lee, Hyewon H and Nestor, Sean M and Downar, Jonathan and Noda, Yoshihiro and Daskalakis, Zafiris J and Mulsant, Benoit H and Blumberger, Daniel M},
  title = {Cognitive Outcomes After Transcranial Magnetic Stimulation for the Treatment of Late-Life Depression: Résultats cognitifs après la stimulation magnétique transcrânienne pour le traitement de la dépression chez les personnes âgées},
  journal = {The Canadian Journal of Psychiatry},
  year = {2025},
  doi = {10.1177/07067437251315515}
}
Kostenlos starten →